Medicover (MCOV B.ST) Stock Price

Medicover Price

OMX·CLOSED
20.00EUR-0.39 (-1.93 %)
Market closed

Over the last 10 years Medicover grew revenue by 19.1% annually, reaching 2.38 B EUR. Earnings per share have grown at 18.7% per year over the last 10 years. For Medicover, the net margin of 3.3% is down versus 7.4% a few years ago. At today's price the dividend yield works out to roughly 0.75%. The payout ratio is around 29% of earnings. The dividend has grown at 21.0% per year over the past 4 years. The consensus 12-month price target for Medicover is 23.37 EUR, about 16.9% above where the stock trades today. Of 9 analysts, 5 rate the stock a buy — an overall Buy consensus. The stock trades about 20% above its 52-week low.

Medicover stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Medicover over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Medicover stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Medicover's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Medicover Stock Price History
DateMedicover Price
8/4/202620.00 EUR
7/31/202620.39 EUR
7/30/202620.46 EUR
7/29/202620.37 EUR
7/28/202620.47 EUR
7/27/202619.92 EUR
7/24/202619.69 EUR
7/23/202619.80 EUR
7/22/202620.48 EUR
7/21/202619.91 EUR
7/20/202620.02 EUR
7/17/202620.15 EUR
7/15/202620.72 EUR
7/14/202620.21 EUR
7/13/202620.58 EUR
7/10/202620.77 EUR
7/9/202620.81 EUR
7/8/202621.11 EUR
7/7/202621.52 EUR
7/6/202621.52 EUR
7/3/202621.49 EUR
7/2/202621.38 EUR
7/1/202621.15 EUR
6/30/202620.75 EUR
6/29/202620.71 EUR
6/26/202620.62 EUR
6/25/202620.49 EUR
6/24/202620.28 EUR
6/23/202619.80 EUR
6/22/202619.53 EUR
6/18/202618.94 EUR
6/17/202619.74 EUR
6/16/202619.25 EUR
6/15/202619.97 EUR
6/12/202619.50 EUR
6/11/202619.32 EUR
6/10/202619.30 EUR
6/9/202619.25 EUR
6/8/202619.25 EUR
6/5/202619.12 EUR
6/4/202619.35 EUR
6/3/202618.66 EUR
6/2/202618.75 EUR
6/1/202618.84 EUR
5/29/202619.16 EUR
5/28/202618.98 EUR
5/27/202619.07 EUR
5/26/202619.39 EUR
5/25/202619.58 EUR
5/22/202619.25 EUR
5/21/202619.53 EUR
5/20/202619.62 EUR
5/19/202619.03 EUR
5/18/202618.25 EUR
5/15/202618.38 EUR
5/13/202618.34 EUR
5/12/202618.04 EUR
5/11/202618.48 EUR
5/8/202618.61 EUR
5/7/202619.16 EUR
5/6/202619.07 EUR
5/5/202618.43 EUR
5/4/202618.52 EUR
4/30/202619.03 EUR
4/29/202619.25 EUR
4/28/202617.70 EUR
4/27/202618.06 EUR
4/24/202618.04 EUR
4/23/202618.23 EUR
4/22/202618.15 EUR
4/21/202618.43 EUR
4/20/202618.61 EUR
4/17/202618.70 EUR
4/16/202618.66 EUR
4/15/202618.43 EUR
4/14/202618.15 EUR
4/13/202618.08 EUR
4/10/202617.77 EUR
4/9/202617.48 EUR
4/8/202617.57 EUR
4/7/202617.13 EUR
4/2/202617.20 EUR
4/1/202617.73 EUR
3/31/202617.26 EUR
3/30/202617.04 EUR
3/27/202616.98 EUR
3/26/202617.16 EUR
3/25/202616.87 EUR
3/24/202616.71 EUR
3/23/202616.87 EUR
3/20/202617.33 EUR
3/19/202617.93 EUR
3/18/202618.04 EUR
3/17/202618.10 EUR
3/16/202618.52 EUR
3/13/202618.93 EUR
3/12/202618.84 EUR
3/11/202618.98 EUR
3/10/202619.16 EUR
3/9/202619.07 EUR
3/6/202619.12 EUR
3/5/202619.07 EUR
3/4/202619.30 EUR
3/3/202619.16 EUR
3/2/202619.94 EUR
2/27/202619.94 EUR
2/26/202619.85 EUR
2/25/202619.53 EUR
2/24/202619.35 EUR
2/23/202619.67 EUR
2/20/202619.94 EUR
2/19/202619.85 EUR
2/18/202619.39 EUR
2/17/202619.21 EUR
2/16/202619.21 EUR
2/13/202619.16 EUR
2/12/202619.07 EUR
2/11/202619.62 EUR
2/10/202620.08 EUR
2/9/202618.57 EUR
2/6/202618.66 EUR
2/5/202618.98 EUR
2/4/202618.84 EUR
2/3/202618.70 EUR
2/2/202618.89 EUR
1/30/202618.57 EUR
1/29/202618.89 EUR
1/28/202619.03 EUR
1/27/202619.25 EUR
1/26/202618.93 EUR
1/23/202618.80 EUR
1/22/202618.80 EUR
1/21/202618.75 EUR
1/20/202618.48 EUR
1/19/202618.80 EUR
1/16/202619.39 EUR
1/15/202619.35 EUR
1/14/202619.67 EUR
1/13/202619.58 EUR
1/12/202619.71 EUR
1/9/202620.03 EUR
1/8/202619.94 EUR
1/7/202619.85 EUR
1/5/202619.07 EUR
1/2/202619.44 EUR
12/30/202520.22 EUR
12/29/202520.22 EUR
12/23/202520.08 EUR
12/22/202520.17 EUR
12/19/202520.13 EUR
12/18/202520.03 EUR
12/17/202519.71 EUR
12/16/202519.80 EUR
12/15/202520.03 EUR
12/12/202520.13 EUR
12/11/202520.31 EUR
12/10/202520.40 EUR
12/9/202520.40 EUR
12/8/202520.40 EUR
12/5/202520.81 EUR
12/4/202521.18 EUR
12/3/202521.27 EUR
12/2/202521.36 EUR
12/1/202521.55 EUR
11/28/202521.59 EUR
11/27/202520.72 EUR
11/26/202520.77 EUR
11/25/202521.00 EUR
11/24/202520.95 EUR
11/21/202520.72 EUR
11/20/202520.91 EUR
11/19/202520.95 EUR
11/18/202521.09 EUR
11/17/202521.59 EUR
11/14/202521.87 EUR
11/13/202521.96 EUR
11/12/202522.33 EUR
11/11/202522.23 EUR
11/10/202521.73 EUR
11/7/202521.50 EUR
11/6/202521.64 EUR
11/5/202521.78 EUR
11/4/202522.33 EUR
11/3/202523.24 EUR
10/31/202523.75 EUR
10/30/202523.88 EUR
10/29/202523.79 EUR
10/28/202523.88 EUR
10/27/202524.16 EUR
10/24/202524.11 EUR
10/23/202523.79 EUR
10/22/202523.70 EUR
10/21/202523.56 EUR
10/20/202523.52 EUR
10/17/202523.61 EUR
10/16/202523.66 EUR
10/15/202523.43 EUR
10/14/202523.66 EUR
10/13/202523.66 EUR
10/10/202523.93 EUR
10/9/202524.11 EUR
10/8/202524.02 EUR
10/7/202523.84 EUR
10/6/202524.07 EUR
10/3/202523.38 EUR
10/2/202523.24 EUR
10/1/202523.43 EUR
9/30/202523.75 EUR
9/29/202523.66 EUR
9/26/202523.70 EUR
9/25/202523.43 EUR
9/24/202523.70 EUR
9/23/202524.16 EUR
9/22/202524.07 EUR
9/19/202524.11 EUR
9/18/202523.93 EUR
9/17/202523.84 EUR
9/16/202523.75 EUR
9/15/202523.93 EUR
9/12/202524.21 EUR
9/11/202524.39 EUR
9/10/202524.66 EUR
9/9/202524.85 EUR
9/8/202524.57 EUR
9/5/202524.57 EUR
9/4/202524.25 EUR
9/3/202523.88 EUR
9/2/202524.07 EUR
9/1/202524.89 EUR
8/29/202524.25 EUR
8/28/202524.34 EUR
8/27/202524.71 EUR
8/26/202524.57 EUR
8/25/202524.71 EUR
8/22/202524.99 EUR
8/21/202524.85 EUR
8/20/202525.08 EUR
8/19/202524.94 EUR
8/18/202525.12 EUR
8/15/202524.89 EUR
8/14/202525.12 EUR
8/13/202525.12 EUR
8/12/202524.94 EUR
8/11/202524.71 EUR
8/8/202524.57 EUR
8/7/202524.57 EUR
8/6/202524.57 EUR
8/5/202524.94 EUR
Access this data via the Eulerpool API
Get Free API Key

Medicover Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
1.51 B EUR
69.00 M EUR
12.10 M EUR
Jan 1, 2023
1.75 B EUR
61.90 M EUR
17.60 M EUR
Jan 1, 2024
2.09 B EUR
89.60 M EUR
16.70 M EUR
Jan 1, 2025
2.38 B EUR
155.70 M EUR
77.50 M EUR
Jan 1, 2026 (e)
2.72 B EUR
198.95 M EUR
109.79 M EUR
Jan 1, 2027 (e)
3.04 B EUR
251.27 M EUR
147.91 M EUR
Jan 1, 2028 (e)
3.36 B EUR
297.76 M EUR
174.19 M EUR
Jan 1, 2029 (e)
3.73 B EUR
355.15 M EUR
170.76 M EUR

Medicover Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 4, 2026, 9:35 PM
 
REVENUEB EUR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM EUR
EBITM EUR
EBIT MARGIN%
NET INCOMEM EUR
NET INCOME GROWTH%
DIV.EUR
DIV. GROWTH%
SHARESM
201520162017201820192020202120222023202420252026e2027e2028e2029e
0.420.500.580.670.841.001.381.511.752.092.382.723.043.363.73
–19.7616.7015.6925.7818.1338.119.6615.6319.7613.7314.4211.6510.5711.02
24.1024.1424.4824.4424.5326.4828.6922.5220.5621.4323.1323.1323.1323.1323.13
100.00120.00142.00164.00207.00264.00395.00340.00359.00448.00550.00629.33702.65776.89862.47
21.0021.0028.0033.0047.0066.00159.0069.0061.0089.00155.00198.00251.00297.00355.00
5.064.234.834.925.576.6211.554.573.494.266.527.288.268.849.52
9.006.0018.0022.0022.0025.00101.0012.0017.0016.0077.00109.00147.00174.00170.00
–-33.33200.0022.22–13.64304.00-88.1241.67-5.88381.2541.5634.8618.37-2.30
––––––0.070.120.120.120.150.200.240.29–
–––––––71.43––25.0033.3320.0020.83–
97.0797.07119.11133.34133.34141.75148.35148.72149.65150.20150.98150.98150.98150.98150.98
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Medicover generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Medicover retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Medicover's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Medicover has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Medicover's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Medicover stock margins

The Medicover margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Medicover. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Medicover.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
28.68 %
11.57 %
7.39 %
Jan 1, 2022
22.54 %
4.57 %
0.80 %
Jan 1, 2023
20.58 %
3.54 %
1.01 %
Jan 1, 2024
21.43 %
4.28 %
0.80 %
Jan 1, 2025
23.16 %
6.55 %
3.26 %
Jan 1, 2026 (e)
23.16 %
7.31 %
4.03 %
Jan 1, 2027 (e)
23.16 %
8.27 %
4.87 %
Jan 1, 2028 (e)
23.16 %
8.86 %
5.19 %

Medicover Stock Revenue, EBIT, Earnings per Share

The Medicover earnings per share therefore indicates how much revenue Medicover has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
9.28 EUR
1.07 EUR
0.69 EUR
Jan 1, 2022
10.15 EUR
0.46 EUR
0.08 EUR
Jan 1, 2023
11.67 EUR
0.41 EUR
0.12 EUR
Jan 1, 2024
13.93 EUR
0.60 EUR
0.11 EUR
Jan 1, 2025
15.75 EUR
1.03 EUR
0.51 EUR
Jan 1, 2026 (e)
18.03 EUR
1.32 EUR
0.73 EUR
Jan 1, 2027 (e)
20.12 EUR
1.66 EUR
0.98 EUR
Jan 1, 2028 (e)
22.25 EUR
1.97 EUR
1.15 EUR

Medicover business model & stock analysis

Medicover AB is a leading healthcare company in Europe with its headquarters in Stockholm, Sweden. The company was founded in 1995 by Fredrik Rågmark with the aim of providing high-quality medical care for patients. Medicover's business model is based on an integrated chain of healthcare services. This includes doctor's offices, specialists, diagnostic centers, hospitals, laboratories, health centers, and nursing services. The company operates in Poland, Romania, Hungary, Germany, Ukraine, and Belarus, and offers a wide range of healthcare services. The main sectors of Medicover include healthcare services for individuals and businesses, as well as the use of cutting-edge technologies and data analysis to improve patient care. The company offers a variety of services in the areas of prevention, diagnosis, and therapy, including laboratory tests, imaging, health checks, medical advice, and treatment of acute and chronic diseases. In the field of corporate services, Medicover offers occupational medicine, corporate health management, as well as health programs and training for employees of companies. This helps promote the health and well-being of employees while achieving higher productivity and efficiency. Products offered by Medicover include insurance services, hospital services, travel medicine, vaccinations, child care, and family planning. The company also offers specialized programs for patients with chronic diseases such as diabetes, hypertension, and cardiovascular diseases. An important component of Medicover's business model is the use of data analysis and technology to improve patient care. The company leverages the latest innovations in medical technology such as telemedicine, electronic health records, and mobile applications to enable faster and more effective access to healthcare. With a strong focus on quality and customer satisfaction, Medicover has become one of the leading healthcare companies in Europe. The company employs over 25,000 employees and serves over 6 million patients per year. In summary, Medicover is an innovative and integrated company in the healthcare industry, specializing in providing high-quality healthcare services and utilizing advanced technologies and data analysis to improve patient care.

Medicover SWOT Analysis

Strengths

Medicover AB has several strengths that contribute to its success:

  • Strong brand reputation and recognition
  • Wide range of healthcare services and solutions
  • Extensive network of clinics and hospitals
  • Highly skilled and experienced medical professionals
  • Advanced medical technology and equipment
  • Strong financial position and stable revenue growth

Weaknesses

Despite its strengths, Medicover AB also has some weaknesses that it should address:

  • Relatively high prices compared to competitors
  • Limited presence in certain geographical areas
  • Dependency on third-party healthcare providers
  • Need for continuous investment in infrastructure and technology
  • Occasional negative press and public perception

Opportunities

There are several opportunities that Medicover AB can leverage for further growth:

  • Increasing demand for private healthcare services
  • Expanding into new geographical markets
  • Developing innovative healthcare solutions and products
  • Partnering with insurance companies for expanded coverage
  • Acquiring or partnering with smaller healthcare providers

Threats

Medicover AB faces various threats that may impact its operations:

  • Intense competition from other private healthcare providers
  • Changing regulatory and legal frameworks
  • Market saturation in certain regions
  • Economic downturns affecting patients' ability to pay for services
  • Technological advancements disrupting traditional healthcare models

Medicover Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Medicover historical P/E ratio, EBIT multiple, and P/S ratio

Medicover annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Medicover shares outstanding

The number of shares of Medicover was 150.98 M in 2025. This indicates how many shares Medicover is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
148.35 M Stocks
Jan 1, 2022
148.72 M Stocks
Jan 1, 2023
149.65 M Stocks
Jan 1, 2024
150.20 M Stocks
Jan 1, 2025
150.98 M Stocks
Jan 1, 2026 (e)
150.98 M Stocks
Jan 1, 2027 (e)
150.98 M Stocks
Jan 1, 2028 (e)
150.98 M Stocks

Medicover Dividend History

6 years of dividend payments

YearAnnual DividendYoY ChangePayments
20260.20EURYTD—1×
Apr 30, 20260.20EUR↑ 33.3%1/1
20250.15EUR↑ 25.0%1×
Apr 30, 20250.15EUR↑ 25.0%1/1
20240.12EUR 0.0%1×
20230.12EUR 0.0%1×
20220.12EUR↑ 71.4%1×
20210.07EUR—1×

Medicover dividend history and estimates

In 2025, Medicover paid a dividend amounting to 0.15 EUR. Dividend means that Medicover distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
0.07 EUR
0.00 EUR
Jan 1, 2022
0.12 EUR
0.00 EUR
Jan 1, 2023
0.12 EUR
0.00 EUR
Jan 1, 2024
0.12 EUR
0.00 EUR
Jan 1, 2025
0.15 EUR
0.00 EUR
Jan 1, 2026
0.20 EUR
0.00 EUR
Jan 1, 2027 (e)
0.00 EUR
0.24 EUR
Jan 1, 2028 (e)
0.00 EUR
0.29 EUR

Medicover dividend payout ratio

In 2025, Medicover had a payout ratio of 29.22%. The payout ratio indicates the percentage of the company's profits that Medicover distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
10.20 %
Jan 1, 2022
147.42 %
Jan 1, 2023
102.04 %
Jan 1, 2024
107.91 %
Jan 1, 2025
29.22 %
Jan 1, 2026 (e)
27.50 %
Jan 1, 2027 (e)
24.50 %
Jan 1, 2028 (e)
24.96 %

Current Medicover forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
55.56 % (5)
Hold
44.44 % (4)
Sell
0.00 % (0)
12M Price Target
23.37
Last Price
20.27
Currency
EUR
12M Return Potential
15.29 %
LTM Return
0 %

Medicover Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
4/25/20240.04EUR-476.72 MEUR-2024 Q1
2/15/20240.03EUR-468.64 MEUR-2023 Q4
11/3/20210.17EUR-316.68 MEUR-2021 Q3
2/14/2020-EUR-229.39 MEUR-2019 Q4
11/6/20190.04EUR-209.09 MEUR-2019 Q3
7/26/20190.04EUR-198.43 MEUR-2019 Q2
2/15/20190.05EUR-179.65 MEUR-2018 Q4

EESG©

Eulerpool ESG Scorecard© for the Medicover stock

78/100
60
Environment
95
Social
77
Governance
E

Environment

20
Scope 1 - Direct Emissions10,620
Scope 2 - Indirect emissions from purchased energy80,762
Scope 3 - Indirect emissions within the value chain414,186
Total CO₂ emissions91,382
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees71
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Medicover shareholder structure

% Name
9.26180%
Fjärde AP-Fonden
Fjärde AP-Fonden
2.64011%
Swedbank Robur Fonder AB
Swedbank Robur Fonder AB
2.48763%
SEB Investment Management AB
SEB Investment Management AB
2.40692%
AMF Tjänstepension AB
AMF Tjänstepension AB
1.84888%
Robert af Jochnick Family
Robert af Jochnick Family
1.24026%
Rågmark (Fredrik)
Rågmark (Fredrik)
...

Medicover Executives and Management Board

19 members · avg. age 59 · 42 % women

Management

JS

Mr. John Stubbington (57)

Chief Executive Officer · since 2025

–
AP

Mr. Anand Patel

Chief Financial Officer

–
KS

Ms. Kamila Skorupinska (52)

Chief People Officer

–
JU

Mr. Jaroslaw Urbanczyk (56)

Chief Information Officer

–
AV

Dr. Andrew Vallance-Owen (73)

Chief Marketing Officer

–
JB

Ms. Jenny Brandt (50)

General Legal Counsel

–

Board of Directors

FR

Mr. Fredrik Ragmark (62)

Director · since 2025

3.31 M EUR
FS

Mr. Fredrik Stenmo (53)

Chairman of the Board

121,000.00 EUR
MF

Mr. Michael Flemming (67)

Independent Director

80,000.00 EUR
SC

Ms. Sonali Chandmal (57)

Independent Director

76,000.00 EUR
MN

Dr. Margareta Nordenvall (70)

Independent Director

68,000.00 EUR
AB

Mr. Arno Bohn (77)

Independent Director

65,000.00 EUR

Frequently asked questions about Medicover

The business model of Medicover AB revolves around providing a comprehensive range of healthcare services to individuals, families, and corporate clients. Medicover AB operates a network of medical clinics, hospitals, and laboratories, offering a wide range of healthcare services such as primary care, specialized care, diagnostics, and outpatient surgery. By integrating healthcare facilities and services, Medicover AB aims to provide high-quality medical care, convenience, and efficient healthcare solutions. This Swedish multinational healthcare company emphasizes patient-centric care and combines medical expertise with the latest technological advancements to ensure optimal health outcomes for its customers. With a strong focus on preventive care, Medicover AB aims to promote and facilitate healthier lifestyles.

Medicover AB is primarily active in the healthcare industry.

The main competitors of Medicover AB in the market include listed healthcare companies such as Capio AB, Ramsay Générale de Santé, and Fresenius SE & Co. KGaA. These competitors operate in various healthcare segments, including primary care, hospital care, and diagnostic services. However, Medicover AB differentiates itself through its integrated healthcare model, providing a comprehensive range of services covering primary and specialty care, diagnostic imaging, and laboratory analysis. With a strong focus on patient-centric care and technological innovation, Medicover AB remains a key player in the competitive healthcare market.

Medicover AB is a renowned healthcare company specializing in medical services, diagnostics, and fertility treatments. Founded in 1995, Medicover has grown to become a leading provider of private healthcare services across Europe. With a strong presence in 15 countries, Medicover offers a wide range of services, including primary care, specialty care, hospital services, and laboratory diagnostics. The company's commitment to exceptional patient care, advanced medical technologies, and innovative solutions has earned them a trusted reputation in the healthcare industry. Medicover AB continues to expand its operations globally, providing quality healthcare solutions to individuals and families worldwide.

Medicover AB, a leading healthcare and diagnostic services provider, has achieved several significant milestones. The company's commitment to providing high-quality healthcare has led to expanding its presence in various countries, resulting in a strong global footprint. Medicover's milestones include successful acquisitions and collaborations with industry leaders to enhance its service offerings and geographic reach. Additionally, the company's focus on innovation and cutting-edge technology has led to the implementation of advanced medical solutions, improving patient outcomes. Medicover AB's remarkable achievements and continuous growth highlight its dedication to providing comprehensive and accessible healthcare solutions to individuals and communities worldwide.

Medicover AB is primarily present in various countries and regions across Europe. With its headquarters in Sweden, Medicover AB has a strong presence in Poland, Romania, Ukraine, Germany, Hungary, and Serbia. Through its extensive network of medical clinics, hospitals, and laboratories, Medicover AB provides a wide range of healthcare services, including primary care, specialist care, diagnostics, and laboratory work. The company's commitment to delivering high-quality healthcare services has earned it a reputation as a trusted healthcare provider in the regions where it operates.

Medicover AB represents a strong commitment to healthcare and quality services. With a focus on patient-centered care, the company promotes accessibility, innovation, and personalized medical solutions. Medicover AB strives to deliver comprehensive healthcare solutions by blending modern technology with a compassionate approach. Their corporate philosophy revolves around continuously improving patient outcomes and enhancing the overall healthcare experience. By combining the expertise of their dedicated professionals and advanced medical facilities, Medicover AB aims to provide exceptional healthcare services to individuals and families. This commitment to excellence and patient well-being is at the core of Medicover AB's values and corporate philosophy.

Analysts currently set an average price target of 24.42 EUR for the Medicover stock (median: 23.37 EUR), implying +20.5 % versus the latest price. The consensus is based on 9 analyst ratings.

Medicover Analyst Price Targets 2026

9 analysts currently rate the Medicover stock: 5 recommend buying, 4 holding and 0 selling. For 2026, analysts expect Medicover to generate revenue of 2.72 B EUR and earnings per share of 0.73 EUR.

Medicover Analyst Price Targets 2026

The Medicover share (MCOV B.ST) is listed on 8 stock exchanges, including: Frankfurt (5M0B.F), München (5M0B.MU), Düsseldorf (5M0B.DU), London (0RPS.L), London (0RPS.L).

Medicover AB is a multinational company operating in the healthcare, diagnostic, and nursing sectors. Its business model focuses on providing comprehensive healthcare to patients, from diagnostics to treatment. Medicover offers a wide range of services including general medicine, dentistry, gynecology, dermatology, ophthalmology, pediatrics, and more. The company also operates its own pharmacies and laboratories, and offers home care, elderly care, and psychiatric care. Medicover has a strong presence in Europe, with clinics and healthcare centers in various countries including Sweden, Poland, Germany, Romania, Hungary, Ukraine, and Slovakia. The company's strategy emphasizes innovation and effectiveness in meeting patients' healthcare needs, through collaboration with doctors and continuous professional development. Technology plays a crucial role in Medicover's business model, with the use of advanced medical devices, IT systems, and telemedicine to improve patient diagnosis and treatment. The company aims to provide comprehensive healthcare by integrating different healthcare services, and offers additional health products such as supplements, vitamins, and painkillers in its pharmacies. Overall, Medicover strives to improve patient healthcare through qualified staff, technology, and collaboration with industry professionals.

The expected revenue of Medicover is 2.72 B EUR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Medicover is 109.79 M EUR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Medicover is currently 27.50. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Medicover stock.

The price-to-sales ratio (P/S) of Medicover is currently 1.11. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Medicover stock.

The Eulerpool Quality Score for Medicover is 7/10.

The ISIN of Medicover is SE0009778848. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Medicover is A2DRQV. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Medicover is MCOV B.ST. The ticker symbol is used to trade Medicover shares on the stock exchange.

Over the past 12 months, Medicover paid a dividend of 0.15 EUR . This corresponds to a dividend yield of about 0.75 %. For the coming 12 months, Medicover is expected to pay a dividend of 0.24 EUR.

The current dividend yield of Medicover is 0.75 %.

Medicover pays a dividend, distributed in the months of , , , .

Medicover paid dividends every year for the past 5 years.

For the upcoming 12 months, dividends amounting to 0.24 EUR are expected. This corresponds to a dividend yield of 1.18 %.

Medicover is assigned to the 'Health' sector.

To receive the latest dividend of Medicover from amounting to 0.2 EUR, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Medicover distributed 0.12 EUR as dividends.

The dividends of Medicover are distributed in EUR.

All fundamentals and in-depth analysis of Medicover

Our stock analysis for Medicover stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medicover. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Medicover Stock
Medicover Revenue→
Medicover Stock
Medicover Net Income→
Medicover Stock
Medicover P/E→
Medicover Stock
Medicover P/S→
Medicover Stock
Medicover EBIT→
Medicover Stock
Medicover Dividend→
Medicover Stock
Medicover Directors Dealings→
Medicover Stock
Medicover Stocks→
Medicover Stock
Medicover Market capitalization→
Medicover Stock
Medicover Debt→
Medicover Stock
Medicover Liabilities→
Medicover Stock
Medicover Equity→
Medicover Stock
Medicover AAQS→
Medicover Stock
Medicover Employees→
Medicover Stock
Medicover ROE→
Medicover Stock
Medicover ROA→
Medicover Stock
Medicover ROCE→
Medicover Stock
Medicover News→
Medicover Stock
Medicover Analyst Price Targets→

Health Stocks

Medicskin HoldingsMedicon HellasMedicureMedicofarma BiotechMedigen BiotechnologyMedico RemediesMedigen Vaccine BiologicsMediclinMedikaloka Hermina Tbk PTMediciNovaMedikit CoMedicine Man TechnologiesAll Stocks A–Z →